CRISPR Therapeutics AG (CRSP)
46.30
-0.96
(-2.03%)
USD |
NASDAQ |
Nov 21, 16:00
46.25
-0.05
(-0.11%)
After-Hours: 20:00
CRISPR Therapeutics Price to Book Value: 2.037 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.080 |
| November 19, 2024 | 2.067 |
| November 18, 2024 | 2.081 |
| November 15, 2024 | 2.079 |
| November 14, 2024 | 2.062 |
| November 13, 2024 | 2.191 |
| November 12, 2024 | 2.232 |
| November 11, 2024 | 2.414 |
| November 08, 2024 | 2.272 |
| November 07, 2024 | 2.283 |
| November 06, 2024 | 2.232 |
| November 05, 2024 | 2.216 |
| November 04, 2024 | 2.226 |
| November 01, 2024 | 2.234 |
| October 31, 2024 | 2.041 |
| October 30, 2024 | 2.109 |
| October 29, 2024 | 2.153 |
| October 28, 2024 | 2.187 |
| October 25, 2024 | 2.084 |
| October 24, 2024 | 2.110 |
| October 23, 2024 | 2.024 |
| October 22, 2024 | 2.114 |
| October 21, 2024 | 2.134 |
| October 18, 2024 | 2.152 |
| October 17, 2024 | 2.124 |
| Date | Value |
|---|---|
| October 16, 2024 | 2.156 |
| October 15, 2024 | 2.114 |
| October 14, 2024 | 2.104 |
| October 11, 2024 | 2.061 |
| October 10, 2024 | 1.997 |
| October 09, 2024 | 1.997 |
| October 08, 2024 | 1.989 |
| October 07, 2024 | 2.001 |
| October 04, 2024 | 1.996 |
| October 03, 2024 | 1.975 |
| October 02, 2024 | 2.011 |
| October 01, 2024 | 2.005 |
| September 30, 2024 | 2.067 |
| September 27, 2024 | 2.034 |
| September 26, 2024 | 1.999 |
| September 25, 2024 | 1.974 |
| September 24, 2024 | 2.012 |
| September 23, 2024 | 2.010 |
| September 20, 2024 | 2.071 |
| September 19, 2024 | 2.128 |
| September 18, 2024 | 2.132 |
| September 17, 2024 | 2.144 |
| September 16, 2024 | 2.052 |
| September 13, 2024 | 2.104 |
| September 12, 2024 | 1.973 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.492
Minimum
May 09 2022
9.329
Maximum
Jan 14 2021
3.423
Average
2.666
Median
Price to Book Value Benchmarks
| Vertex Pharmaceuticals Inc | 7.420 |
| AC Immune SA | 2.101 |
| Addex Therapeutics Ltd | 0.6249 |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 1.192 |
Price to Book Value Related Metrics
| Price | 46.30 |
| Earnings Yield | -6.05% |
| Market Cap | 3.952B |